Argentum Pharmaceuticals is Drug Discovery in United States that focus on secure financial concessions business. They cover business area such as operator, generic drug company, prescription drug, innovative and cost-effective treatment option, patient, new generic drug, review, pharmaceutical patent, any true innovative contribution, secure financial concession, brand drug, consumer, payor.
-
Secure Financial Concessions
-
134 Spring Street
Suite 301
New York, NY 10012
United States
Private
operatorgeneric drug companyprescription druginnovative and cost-effective treatment optionpatientnew generic drugreviewpharmaceutical patentany true innovative contributionsecure financial concessionbrand drugconsumerpayor
* We use standard office opening hours in near Argentum Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Argentum Pharmaceuticals is Drug Discovery business from United States that founded in - ( years old in ), Argentum Pharmaceuticals business is focusing on Secure Financial Concessions.
Argentum Pharmaceuticals headquarter office and corporate office address is located in 134 Spring Street Suite 301 New York, NY 10012 United States.
Argentum Pharmaceuticals was founded in United States.
In , Argentum Pharmaceuticals is currently focus on secure financial concessions sector.
Above is snippet of Google Trends for "secure financial concessions" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Argentum Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
